Amryt Pharma
Shir Fuchs Orenbach, MD, MSc has worked as a Senior Director, Global Clinical Research Physician at Amryt Pharma plc since September 2021. Prior to this, they served as a Senior Director Clinical Development at Chiasma from February 2021 to January 2022. From July 2017 to February 2021, they held the role of Medical Manager at Neuroderm.
Dr. Shir Fuchs Orenbach received a Bachelor of Science degree in biomedical engineering from Tel Aviv University in 2009. Shir then pursued a Master of Science degree in biomedical engineering from the same university, which they completed in 2011. Following this, from 2011 to 2015, they attended Tel Aviv University for their medical studies, specializing in the field of medicine.
This person is not in any offices
Amryt Pharma
Amryt is a biopharmaceutical company focused on developing and delivering innovative new treatments to help improve the lives of patients with rare and orphan diseases.